Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
86,096,158
-
Share change
-
+8,887,672
-
Total reported value
-
$657,561,692
-
Put/Call ratio
-
54%
-
Price per share
-
$7.63
-
Number of holders
-
207
-
Value change
-
+$65,745,110
-
Number of buys
-
90
-
Number of sells
-
67
Institutional Holders of SORRENTO THERAPEUTICS INC - COMMON STOCK (SRNE) as of Q3 2021
As of 30 Sep 2021 SORRENTO THERAPEUTICS INC - COMMON STOCK (SRNE) had 207 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 86,096,158 shares of stock of the company.
Largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, D. E. Shaw & Co., Inc., JPMORGAN CHASE & CO, NORTHERN TRUST CORP, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, SABBY MANAGEMENT, LLC, and Bank of New York Mellon Corp.
This table shows 207 institutional shareholders of the security as of 30 Sep 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.